Blood-based biomarker candidates of cerebral amyloid using PiB PET in non-demented elderly

Increasingly, clinical trials for Alzheimer’s disease (AD) are being conducted earlier in the disease phase and with biomarker confirmation using in vivo amyloid PET imaging or CSF tau and Aβ measures to quantify pathology. However, making such a pre-clinical AD diagnosis is relatively costly and th...

Descripció completa

Dades bibliogràfiques
Autors principals: Westwood, S, Leoni, E, Hye, A, Baird, A, Lovestone, S
Format: Journal article
Publicat: IOS Press 2016

Ítems similars